{"id":270072,"date":"2026-09-25T10:21:59","date_gmt":"2026-09-25T04:51:59","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=270072"},"modified":"2026-09-25T10:21:59","modified_gmt":"2026-09-25T04:51:59","slug":"why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-25","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-25\/","title":{"rendered":"Glenmark Pharmaceuticals (GLENMARK) Share Price Falls 2.38% as Stock Ends at Rs 2,383.80"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/glenmark\/glenmark-pharmaceuticals-ltd-share-price-today\">Glenmark Pharmaceuticals (GLENMARK)<\/a> share price fell to Rs 2,383.8 today, down 2.38% from the previous close. Market cap was Rs 69,768.76 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong>&nbsp;&nbsp;&nbsp;25 September 2026 at 10:19:19 AM IST<\/p>\n<div>\n<p style=\"margin-top:0!important;\">Glenmark Pharmaceuticals Share Price fell to Rs 2,383.80 today, down 2.38% from the previous close, and the company\u2019s market capitalisation stands at Rs 69,768.76 Cr. The move places Glenmark Pharmaceuticals in focus for Glenmark Pharmaceuticals Share Price Today searches, Glenmark Pharmaceuticals Stock News and Glenmark Pharmaceuticals Share Price Fall queries. The day\u2019s data confirms the price event, but it does not establish a company-specific catalyst. In that setting, Univest is tracking the stock through a factual lens: what changed in the session, how the valuation compares with healthcare peers, and what the supplied fundamentals say about Glenmark Pharmaceuticals Share Price now.<\/p>\n<p>Today\u2019s decline also matters because the stock opened below the previous close and finished near the day\u2019s lower end, while the company remains a Large Cap by the supplied market-cap category. Univest is using only the verified figures in this Glenmark Pharmaceuticals Share Price news update, without adding a reason that is not supported by the data.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-25\/#Glenmark_Pharmaceuticals_GLENMARK_Share_Price_Today_Price_Action_Analysis\" title=\"Glenmark Pharmaceuticals (GLENMARK) Share Price Today: Price Action Analysis\">Glenmark Pharmaceuticals (GLENMARK) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-25\/#Glenmark_Pharmaceuticals_GLENMARK_Fundamental_Analysis\" title=\"Glenmark Pharmaceuticals (GLENMARK) Fundamental Analysis\">Glenmark Pharmaceuticals (GLENMARK) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-25\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-25\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-25\/#Why_Investors_Are_Watching_Glenmark_Pharmaceuticals\" title=\"Why Investors Are Watching Glenmark Pharmaceuticals\">Why Investors Are Watching Glenmark Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-25\/#About_Glenmark_Pharmaceuticals\" title=\"About Glenmark Pharmaceuticals\">About Glenmark Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-25\/#Track_Glenmark_Pharmaceuticals_Share_Price_on_Univest\" title=\"Track Glenmark Pharmaceuticals Share Price on Univest\">Track Glenmark Pharmaceuticals Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-25\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-25\/#Why_did_Glenmark_Pharmaceuticals_Share_Price_fall_today\" title=\"Why did Glenmark Pharmaceuticals Share Price fall today?\">Why did Glenmark Pharmaceuticals Share Price fall today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-25\/#What_is_Glenmark_Pharmaceuticals_Share_Price_Today\" title=\"What is Glenmark Pharmaceuticals Share Price Today?\">What is Glenmark Pharmaceuticals Share Price Today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-25\/#What_is_Glenmark_Pharmaceuticals_market_capitalisation\" title=\"What is Glenmark Pharmaceuticals market capitalisation?\">What is Glenmark Pharmaceuticals market capitalisation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-25\/#How_does_Glenmark_Pharmaceuticals_compare_on_valuation\" title=\"How does Glenmark Pharmaceuticals compare on valuation?\">How does Glenmark Pharmaceuticals compare on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-25\/#What_do_ROE_and_ROCE_show_for_Glenmark_Pharmaceuticals\" title=\"What do ROE and ROCE show for Glenmark Pharmaceuticals?\">What do ROE and ROCE show for Glenmark Pharmaceuticals?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-25\/#How_does_Glenmark_Pharmaceuticals_compare_with_healthcare_peers\" title=\"How does Glenmark Pharmaceuticals compare with healthcare peers?\">How does Glenmark Pharmaceuticals compare with healthcare peers?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Glenmark_Pharmaceuticals_GLENMARK_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Glenmark Pharmaceuticals (GLENMARK) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,383.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,442<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 58.20 (-2.38%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,422.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,433<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,380.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5.08 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 69,768.76 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Glenmark Pharmaceuticals Share Price Today shows a clear down day in a session that began at Rs 2,422.70, compared with the previous close of Rs 2,442. The stock moved between a day high of Rs 2,433.00 and a day low of Rs 2,380.60 before ending at Rs 2,383.80. That leaves the day change at Rs -58.20, or -2.38%. In simple terms, Glenmark Pharmaceuticals Share Price moved lower from the opening print and settled close to the session low.<\/p>\n<p>The turnover for the day is Rs 5.08 Cr. On the market-cap side, Glenmark Pharmaceuticals remains classified as a Large Cap, with market capitalisation of Rs 69,768.76 Cr. For readers following Glenmark Pharmaceuticals Share Price Live, the day\u2019s numbers are important because they show a decline in the listed price without assigning a cause that the data does not verify. The session also keeps Glenmark Pharmaceuticals Stock News in focus for investors scanning same-day movers in the healthcare space. From here, the next useful step is to examine the company\u2019s fundamentals, which help place the day\u2019s share price fall in broader context.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Glenmark_Pharmaceuticals_GLENMARK_Fundamental_Analysis\"><\/span><strong>Glenmark Pharmaceuticals (GLENMARK) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 69,768.76 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">38.33x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6.29x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 63.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 388.43<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.1%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Glenmark Pharmaceuticals Share Price is trading against a valuation backdrop that includes a P\/E ratio of 38.33 and a P\/B ratio of 6.29. These numbers are above the same-industry medians of 32.73 for P\/E and 2.95 for P\/B, based on a 199-company benchmark set in Pharmaceuticals &amp; Drugs. That comparison suggests the stock is priced richer than the industry median on both metrics, even before today\u2019s decline is considered.<\/p>\n<p>The company\u2019s ROE stands at 14.10% and ROCE at 20.35%, both above the industry medians of 11.70% and 13.61% respectively. EPS is Rs 63.70, book value is Rs 388.43 and dividend yield is 0.10%. Those figures add useful depth to Glenmark Pharmaceuticals Fundamental Analysis because they show earnings per share, accounting net worth per share and the historical payout rate in one view. With Glenmark Pharmaceuticals Market Cap at Rs 69,768.76 Cr, Univest sees a profile that combines large-scale valuation, solid return ratios and a modest dividend yield. Glenmark Pharmaceuticals Financial Results and future disclosures will remain important for anyone tracking how the stock\u2019s valuation compares with its own performance base, but the current article stays confined to the verified figures supplied here.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">38.33x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.73x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.58x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.48x to 757.76x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6.29x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.95x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.37x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.61%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 69,768.76 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 804.62 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,476.05 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Glenmark Pharmaceuticals operates in Healthcare, within the Pharmaceuticals &amp; Drugs industry, and the sector benchmark supplied here covers 199 companies in the same industry. In that benchmark, the company\u2019s P\/E of 38.33 sits above the median of 32.73 but below the average of 49.58. Its P\/B of 6.29 is also above the industry median of 2.95 and below the average of 4.37? Actually, the supplied average is 4.37 and the company is above it, which keeps the stock on the richer side of the peer set on book-value terms.<\/p>\n<p>On return ratios, Glenmark Pharmaceuticals\u2019 ROE of 14.10% is above the industry median of 11.70% and the average of 10.70%. ROCE at 20.35% is also above the median of 13.61% and the average of 13.40%. The market-cap benchmark is broad: the same-industry median is Rs 804.62 Cr and the average is Rs 14,476.05 Cr, while the maximum reaches Rs 4,47,475.97 Cr. Against that field, Glenmark Pharmaceuticals Share Price reflects a company that is well above the typical industry size and sits in the Large Cap bracket. For Glenmark Pharmaceuticals Stock Analysis, the sector takeaway is straightforward: valuation is above the industry median, while return ratios also stand above the median and average. Univest notes that this combination can shape how investors read Glenmark Pharmaceuticals Share News, especially when a same-day decline appears against a higher-than-median valuation backdrop.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,47,475.97<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,54,763.56<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">87.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,89,423.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.91<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,16,658.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.08<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,11,484.47<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.23<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Glenmark Pharmaceuticals Share Price can also be read against the supplied peer set. The closest comparison points include Sun Pharmaceutical Industries at a P\/E of 36.76 and market cap of Rs 4,47,475.97 Cr, Divi&#8217;s Laboratories at a P\/E of 87.25 and market cap of Rs 2,54,763.56 Cr, and Torrent Pharmaceuticals at a P\/E of 86.07 and market cap of Rs 1,89,423.19 Cr. Zydus Lifesciences shows a P\/E of 26.08 and market cap of Rs 1,16,658.07 Cr, while Cipla stands at a P\/E of 33.65 and market cap of Rs 1,11,484.47 Cr.<\/p>\n<p>On that set, Glenmark Pharmaceuticals\u2019 P\/E of 38.33 is higher than Sun Pharmaceutical and Cipla, but lower than Divi\u2019s Laboratories and Torrent Pharmaceuticals. Its P\/B of 6.29 is above Sun Pharmaceutical\u2019s 5.14, Zydus Lifesciences\u2019 4.37 and Cipla\u2019s 3.23, but below Divi\u2019s Laboratories\u2019 14.45 and Torrent Pharmaceuticals\u2019 20.91. ROE at 14.10% sits below Zydus Lifesciences\u2019 19.69% and Torrent Pharmaceuticals\u2019 26.76%, while ROCE at 20.35% is above Sun Pharmaceutical\u2019s 19.11% and Cipla\u2019s 16.00%, but below Zydus Lifesciences\u2019 21.39% and Divi\u2019s Laboratories\u2019 21.51%. For Glenmark Pharmaceuticals Share Price Today, the peer set shows a company that is neither the cheapest nor the most expensive in the basket, with return ratios that sit in the middle of the group.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Glenmark_Pharmaceuticals\"><\/span><strong>Why Investors Are Watching Glenmark Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Glenmark Pharmaceuticals Share Price fell 2.38% today to Rs 2,383.80 from the previous close of Rs 2,442.<\/li>\n<li>The day\u2019s price range was Rs 2,380.60 to Rs 2,433.00, with opening price at Rs 2,422.70.<\/li>\n<li>Market capitalisation stands at Rs 69,768.76 Cr, and the company is classified as Large Cap.<\/li>\n<li>P\/E of 38.33 and P\/B of 6.29 place Glenmark Pharmaceuticals above the industry median on both valuation measures.<\/li>\n<li>ROE of 14.10%, ROCE of 20.35%, EPS of Rs 63.70 and book value of Rs 388.43 provide the main fundamental context.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Glenmark_Pharmaceuticals\"><\/span><strong>About Glenmark Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Glenmark Pharmaceuticals operates in Healthcare and is classified under the Pharmaceuticals &amp; Drugs industry. The supplied data places it in the Large Cap category with a market capitalisation of Rs 69,768.76 Cr. For investors following Glenmark Pharmaceuticals Company News, the most relevant facts in this update are the sector classification, the valuation profile and the day\u2019s share price movement. Glenmark Pharmaceuticals Share Price remains a stock-market event driven by verified session data and comparative financial metrics rather than by any unsupported narrative.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Glenmark_Pharmaceuticals_Share_Price_on_Univest\"><\/span><strong>Track Glenmark Pharmaceuticals Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use&nbsp;<a href=\"https:\/\/univest.in\/stocks\/glenmark\/glenmark-pharmaceuticals-ltd-share-price-today\">Glenmark Pharmaceuticals (GLENMARK) live share-price page<\/a>,<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top decliners and related market analysis.<\/p>\n<p>Univest lets users track Glenmark Pharmaceuticals Share Price, Glenmark Pharmaceuticals Share Price Today, Glenmark Pharmaceuticals Stock News and Glenmark Pharmaceuticals Latest News in one place. Readers can also follow live price, financial ratios, shareholding pattern, 52-week levels and market insights on Univest for structured stock tracking.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong>&nbsp;&nbsp;Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Glenmark_Pharmaceuticals_Share_Price_fall_today\"><\/span><strong>Why did Glenmark Pharmaceuticals Share Price fall today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;The supplied data shows Glenmark Pharmaceuticals Share Price fell 2.38% to Rs 2,383.80, but it does not establish a company-specific catalyst. The article therefore treats this as a verified price event only.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Glenmark_Pharmaceuticals_Share_Price_Today\"><\/span><strong>What is Glenmark Pharmaceuticals Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Glenmark Pharmaceuticals Share Price Today is Rs 2,383.80, compared with the previous close of Rs 2,442. The stock declined Rs 58.20 during the session and finished near the day\u2019s low.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Glenmark_Pharmaceuticals_market_capitalisation\"><\/span><strong>What is Glenmark Pharmaceuticals market capitalisation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Glenmark Pharmaceuticals has a market capitalisation of Rs 69,768.76 Cr. The supplied market-cap category is Large Cap, which provides company-size context alongside the day\u2019s share price fall and valuation data.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Glenmark_Pharmaceuticals_compare_on_valuation\"><\/span><strong>How does Glenmark Pharmaceuticals compare on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Glenmark Pharmaceuticals has a P\/E of 38.33 and P\/B of 6.29. Both are above the industry medians of 32.73 and 2.95 in the same Pharmaceuticals &amp; Drugs benchmark. The company trades at a P\/E ratio of 38.33x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_ROE_and_ROCE_show_for_Glenmark_Pharmaceuticals\"><\/span><strong>What do ROE and ROCE show for Glenmark Pharmaceuticals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Glenmark Pharmaceuticals reports ROE of 14.10% and ROCE of 20.35%. Both are above the same-industry medians, which gives useful context for Glenmark Pharmaceuticals Share Price and its valuation profile. ROE stands at 14.1%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Glenmark_Pharmaceuticals_compare_with_healthcare_peers\"><\/span><strong>How does Glenmark Pharmaceuticals compare with healthcare peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Glenmark Pharmaceuticals sits between peers on key metrics. Its P\/E of 38.33 is above Cipla and Sun Pharmaceutical, but below Divi\u2019s Laboratories and Torrent Pharmaceuticals, while ROCE is above Sun Pharmaceutical and Cipla.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Glenmark Pharmaceuticals Share Price falls to Rs 2,383.8. marking a 2.38% fall today. Market cap stands at Rs 69,768.76 crore.<\/p>\n","protected":false},"author":29,"featured_media":270070,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-270072","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["270070"],"rank_math_title":["Glenmark Pharmaceuticals Share Price Fall: Key Trade Facts"],"rank_math_description":["Glenmark Pharmaceuticals Share Price fell 2.38% to Rs 2,383.80. Read today\u2019s price action, valuation, sector context and peer comparison."],"rank_math_focus_keyword":["Glenmark Pharmaceuticals Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/glenmark-pharmaceuticals-glenmark-share-price-falls-2-38-as-stock-ends-at-rs-2.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/270072","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=270072"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/270072\/revisions"}],"predecessor-version":[{"id":270074,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/270072\/revisions\/270074"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/270070"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=270072"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=270072"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=270072"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}